Literature DB >> 17659638

Deep brain stimulation for the treatment of atypical parkinsonism.

Ludy C Shih1, Daniel Tarsy.   

Abstract

Deep brain stimulation (DBS) has gained widespread acceptance for improving motor function and disability in Parkinson's disease (PD). Patients with features suggestive of atypical parkinsonism (AP) usually have a poorer and less sustained response to levodopa and a poorer prognosis overall when compared with patients with PD. However, experience in the use of DBS with this group of patients is limited and evidence is lacking with regards to its efficacy and adverse effects. We review in detail the experience of DBS surgery in patients with several forms of AP including multiple system atrophy. On the basis of the limited available data reviewed here, DBS for patients with AP is not recommended. (c) 2007 Movement Disorder Society.

Entities:  

Mesh:

Year:  2007        PMID: 17659638     DOI: 10.1002/mds.21648

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  18 in total

Review 1.  Surgical treatment of Parkinson disease: past, present, and future.

Authors:  Andrew P Duker; Alberto J Espay
Journal:  Neurol Clin       Date:  2013-04-04       Impact factor: 3.806

Review 2.  Pathophysiology of parkinsonism.

Authors:  Adriana Galvan; Thomas Wichmann
Journal:  Clin Neurophysiol       Date:  2008-05-07       Impact factor: 3.708

3.  Deep brain stimulation response in pathologically confirmed cases of multiple system atrophy.

Authors:  Michael Ullman; Vinata Vedam-Mai; Andrew S Resnick; Anthony T Yachnis; Nikolaus R McFarland; Stacy Merritt; Pamela Zeilman; Kelly D Foote; Michael S Okun
Journal:  Parkinsonism Relat Disord       Date:  2011-10-07       Impact factor: 4.891

4.  Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations.

Authors:  Ji Hyun Ko; Chong Sik Lee; David Eidelberg
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-21       Impact factor: 6.200

5.  FDG PET in the Evaluation of Parkinson's Disease.

Authors:  Kathleen L Poston; David Eidelberg
Journal:  PET Clin       Date:  2010-01-01

6.  Multiple system atrophy: current and future approaches to management.

Authors:  Olivier Flabeau; Wassilios G Meissner; François Tison
Journal:  Ther Adv Neurol Disord       Date:  2010-07       Impact factor: 6.570

7.  Localizing parkinsonism based on focal brain lesions.

Authors:  Juho Joutsa; Andreas Horn; Joey Hsu; Michael D Fox
Journal:  Brain       Date:  2018-08-01       Impact factor: 13.501

Review 8.  Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues.

Authors:  Jeff M Bronstein; Michele Tagliati; Ron L Alterman; Andres M Lozano; Jens Volkmann; Alessandro Stefani; Fay B Horak; Michael S Okun; Kelly D Foote; Paul Krack; Rajesh Pahwa; Jaimie M Henderson; Marwan I Hariz; Roy A Bakay; Ali Rezai; William J Marks; Elena Moro; Jerrold L Vitek; Frances M Weaver; Robert E Gross; Mahlon R DeLong
Journal:  Arch Neurol       Date:  2010-10-11

9.  Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography.

Authors:  Madhavi Tripathi; Vijay Dhawan; Shichun Peng; Suman Kushwaha; Amit Batla; Abhinav Jaimini; Maria M D'Souza; Rajnish Sharma; Sanjiv Saw; Anupam Mondal
Journal:  Neuroradiology       Date:  2013-01-13       Impact factor: 2.804

10.  Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis.

Authors:  Chris C Tang; Kathleen L Poston; Thomas Eckert; Andrew Feigin; Steven Frucht; Mark Gudesblatt; Vijay Dhawan; Martin Lesser; Jean-Paul Vonsattel; Stanley Fahn; David Eidelberg
Journal:  Lancet Neurol       Date:  2010-01-08       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.